Collectively, the RPPA and Western blot data indicate that roughly two thirds of NOTCH1-wt HNSCC tumor lines have little to no baseline activation of the NOTCH1 pathway (Figure 6B). This evidence concerns the gene NOTCH1 and neoplasm.